![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mark Pucci, Nadia Sarween, Ellen Knox, Graham Lipkin & Una Martin. (2015) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits. Expert Review of Clinical Pharmacology 8:2, pages 221-231.
Read now
Read now
Laura A Magee, Shirin Namouz-Haddad, Vivien Cao, Gideon Koren & Peter von Dadelszen. (2015) Labetalol for hypertension in pregnancy. Expert Opinion on Drug Safety 14:3, pages 453-461.
Read now
Read now
Grigory Sidorenkov & Gerjan Navis. (2014) Safety of ACE inhibitor therapies in patients with chronic kidney disease. Expert Opinion on Drug Safety 13:10, pages 1383-1395.
Read now
Read now
Articles from other publishers (54)
Line Malha, Tiina Podymow & Phyllis August. 2024. Hypertension. Hypertension
501
517
.
Thays Calista Santiago, Larissa Parra, João V. Nani, Thiago M. Fidalgo, Nicholas J. Bradshaw & Mirian A. F. Hayashi. (2023) Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders. Journal of Neurochemistry 166:2, pages 138-155.
Crossref
Crossref
Bénédicte Coulm, Mathilde Latour, Delphine Beguin, Catherine Vauzelle, Elisabeth Éléfant, Tim Ulinski & Benoît Marin. (2023) Toxicité fœtale et néonatale des inhibiteurs de l’enzyme de conversion et des sartans : quelle surveillance pour les enfants exposés in utero ?. Gynécologie Obstétrique Fertilité & Sénologie 51:6, pages 352-355.
Crossref
Crossref
Laila Ülkü Demir, Elisabeth Reinhardt Mathiesen, Peter Damm & Lene Ringholm. (2023) Major congenital malformations in offspring of women with chronic diseases—impact of the disease or the treatment?. AJOG Global Reports 3:1, pages 100153.
Crossref
Crossref
John H. Wilson. 2023. Maternal Cardiac Care. Maternal Cardiac Care
98
102
.
Albertina M. Ghelfi & Gustavo J. Staffieri. (2022) Hipertensión arterial en la mujer en edad fértil no gestante. Medicina Clínica 159:2, pages 101-105.
Crossref
Crossref
Albertina M. Ghelfi & Gustavo J. Staffieri. (2022) Hypertension in non-pregnant women of childbearing age. Medicina Clínica (English Edition) 159:2, pages 101-105.
Crossref
Crossref
Laura A. Magee, Graeme N. Smith, Christine Bloch, Anne-Marie Côté, Venu Jain, Kara Nerenberg, Peter von Dadelszen, Michael Helewa & Evelyne Rey. (2022) Directive clinique no 426 : Troubles hypertensifs de la grossesse : Diagnostic, prédiction, prévention et prise en charge. Journal of Obstetrics and Gynaecology Canada 44:5, pages 572-597.e1.
Crossref
Crossref
Laura A. Magee, Graeme N. Smith, Christine Bloch, Anne-Marie Côté, Venu Jain, Kara Nerenberg, Peter von Dadelszen, Michael Helewa & Evelyne Rey. (2022) Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management. Journal of Obstetrics and Gynaecology Canada 44:5, pages 547-571.e1.
Crossref
Crossref
Laura A Magee, Mark A. Brown, David R. Hall, Sanjay Gupte, Annemarie Hennessy, S. Ananth Karumanchi, Louise C. Kenny, Fergus McCarthy, Jenny Myers, Liona C. Poon, Sarosh Rana, Shigeru Saito, Anne Cathrine Staff, Eleni Tsigas & Peter von Dadelszen. (2022) The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertension 27, pages 148-169.
Crossref
Crossref
Laura A. Magee, Asma Khalil, Nikos Kametas & Peter von Dadelszen. (2022) Toward personalized management of chronic hypertension in pregnancy. American Journal of Obstetrics and Gynecology 226:2, pages S1196-S1210.
Crossref
Crossref
Juan Tamargo, Ricardo Caballero & Eva Delpón. (2022) Sex-related differences in the pharmacological treatment of heart failure. Pharmacology & Therapeutics 229, pages 107891.
Crossref
Crossref
Christianne de Groot, Jason G. Umans, Arun Jeyabalan & Anne Cathrine Staff. 2022. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
375
403
.
Jennifer Fu, George Tomlinson & Denice S. Feig. (2021) Increased risk of major congenital malformations in early pregnancy use of angiotensin‐converting‐enzyme inhibitors and angiotensin‐receptor‐blockers: a meta‐analysis. Diabetes/Metabolism Research and Reviews 37:8.
Crossref
Crossref
Jessica Saunders, Allison Marie Callejas Salgado, Joseph Y Ting, Cherry Mammen, Jefferson Terry & Jonathan W Bush. (2021) Quantifying Proximal Collecting Tubule Deficiency in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Fetopathy. Pediatric and Developmental Pathology 24:5, pages 438-444.
Crossref
Crossref
A.M. Ghelfi, M.V. Ferretti & G.J. Staffieri. (2021) Tratamiento farmacológico de la hipertensión arterial no severa durante el embarazo, el posparto y la lactancia. Hipertensión y Riesgo Vascular 38:3, pages 133-147.
Crossref
Crossref
Sarah Petch, Emily O'Connor, Ailbhe McGrath & Sean Daly. (2021) Valsartan exposure in pregnancy with resultant anhydramnios and chronic kidney disease in a late preterm infant. BMJ Case Reports 14:5, pages e240810.
Crossref
Crossref
Laura A. Magee & Peter von Dadelszen. (2021) Management of Hypertension in Pregnancy. Maternal-Fetal Medicine 3:2, pages 124-135.
Crossref
Crossref
Juan Tamargo, Niti R. Aggarwal & María Tamargo. 2021. Sex Differences in Cardiac Diseases. Sex Differences in Cardiac Diseases
597
642
.
Nida Buawangpong, Supanimit Teekachunhatean & Nut Koonrungsesomboon. (2020) Adverse pregnancy outcomes associated with first‐trimester exposure to angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta‐analysis. Pharmacology Research & Perspectives 8:5.
Crossref
Crossref
Meghana A. Limaye, Jill P. Buyon, Bettina F. Cuneo & Shilpi S. Mehta‐Lee. (2020) A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. Prenatal Diagnosis 40:9, pages 1066-1076.
Crossref
Crossref
Xabier Cendoya, Celia Quevedo, Maitane Ipiñazar & Francisco J. Planes. (2020) Computational approach for collection and prediction of molecular initiating events in developmental toxicity. Reproductive Toxicology 94, pages 55-64.
Crossref
Crossref
Laura A. Magee & Peter von Dadelszen. (2018) State-of-the-Art Diagnosis and Treatment of Hypertension in Pregnancy. Mayo Clinic Proceedings 93:11, pages 1664-1677.
Crossref
Crossref
Marine Lallemant, Sarah Prévost, François Nobili, Didier Riethmuller, Rajeev Ramanah, Marie-France Seronde & Nicolas Mottet. (2018) Prenatal hypocalvaria after prolonged intrauterine exposure to angiotensin II receptor antagonists. Journal of the Renin-Angiotensin-Aldosterone System 19:4, pages 147032031881094.
Crossref
Crossref
Christopher Thiam Seong Lim & Fuah Kar Wah. (2018) Pregnancy and Peritoneal Dialysis: An Updated Review. EMJ Nephrology, pages 74-84.
Crossref
Crossref
Denice S. Feig, Howard Berger, Lois Donovan, Ariane Godbout, Tina Kader, Erin Keely & Rema Sanghera. (2018) Diabetes and Pregnancy. Canadian Journal of Diabetes 42, pages S255-S282.
Crossref
Crossref
Jorieke E. H. Bergman, L. Renée Lutke, Rijk O. B. Gans, Marie-Claude Addor, Ingeborg Barisic, Clara Cavero-Carbonell, Ester Garne, Miriam Gatt, Kari Klungsoyr, Nathalie Lelong, Catherine Lynch, Olatz Mokoroa, Vera Nelen, Amanda J. Neville, Anna Pierini, Hanitra Randrianaivo, Anke Rissmann, David Tucker, Awi Wiesel, Helen Dolk, Maria Loane & Marian K. Bakker. (2017) Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study. Drug Safety 41:4, pages 415-427.
Crossref
Crossref
Jessica Tangren, Molly Nadel & Michelle A. Hladunewich. (2018) Pregnancy and End-Stage Renal Disease. Blood Purification 45:1-3, pages 194-200.
Crossref
Crossref
Line Malha, Tiina Podymow & Phyllis August. 2018. Hypertension: A Companion to Braunwald's Heart Disease. Hypertension: A Companion to Braunwald's Heart Disease
361
373
.
Amanda J. Stolarz & Nancy J. Rusch. 2018. Gender Differences in the Pathogenesis and Management of Heart Disease. Gender Differences in the Pathogenesis and Management of Heart Disease
287
302
.
Montserrat Balsells, Apolonia García‐Patterson, Juan María Adelantado & Rosa Corcoy. 2017. A Practical Manual of Diabetes in Pregnancy. A Practical Manual of Diabetes in Pregnancy
141
152
.
J Tamargo, G Rosano, T Walther, J Duarte, A Niessner, JC Kaski, C Ceconi, H Drexel, K Kjeldsen, G Savarese, C Torp-Pedersen, D Atar, BS Lewis & S Agewall. (2017) Gender differences in the effects of cardiovascular drugs. European Heart Journal - Cardiovascular Pharmacotherapy 3:3, pages 163-182.
Crossref
Crossref
Brian T. Bateman, Elisabetta Patorno, Rishi J. Desai, Ellen W. Seely, Helen Mogun, Sara Z. Dejene, Michael A. Fischer, Alexander M. Friedman, Sonia Hernandez-Diaz & Krista F. Huybrechts. (2017) Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations. Obstetrics & Gynecology 129:1, pages 174-184.
Crossref
Crossref
Matteo Cassina, Giulia A. Cagnoli, Daniela Zuccarello, Elena Di Gianantonio & Maurizio Clementi. (2017) Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation. European Journal of Medical Genetics 60:1, pages 22-31.
Crossref
Crossref
E. Koch & S. Plassmann. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
7
38
.
Geena Joseph, Sarah L. Housman & Melanie P. Hoenig. 2017. Medical Problems During Pregnancy. Medical Problems During Pregnancy
163
189
.
Ryohei Yamamoto. 2016. Pathogenesis and Treatment in IgA Nephropathy. Pathogenesis and Treatment in IgA Nephropathy
263
301
.
Amanda J. Stolarz & Nancy J. Rusch. (2015) Gender Differences in Cardiovascular Drugs. Cardiovascular Drugs and Therapy 29:4, pages 403-410.
Crossref
Crossref
L. Foo, J. Tay, C. C. Lees, C. M. McEniery & I. B. Wilkinson. (2015) Hypertension in Pregnancy: Natural History and Treatment Options. Current Hypertension Reports 17:5.
Crossref
Crossref
Mark R. Morton & William M. Hague. 2015. Case Studies in Assisted Reproduction. Case Studies in Assisted Reproduction
7
11
.
Yifat Gadot & Gideon Koren. 2015. Optimizing Treatment for Children in the Developing World. Optimizing Treatment for Children in the Developing World
65
70
.
Yifat Gadot & Gideon Koren. 2015. Medicines For Women. Medicines For Women
97
137
.
Melissa A. Cadnapaphornchai, Diana M. George, Kim McFann, Wei Wang, Berenice Gitomer, John D. Strain & Robert W. Schrier. (2014) Effect of Pravastatin on Total Kidney Volume, Left Ventricular Mass Index, and Microalbuminuria in Pediatric Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology 9:5, pages 889-896.
Crossref
Crossref
Peter W. G. Tennant, Svetlana V. Glinianaia, Rudy W. Bilous, Judith Rankin & Ruth Bell. (2014) Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter]. Diabetologia 57:5, pages 1084-1085.
Crossref
Crossref
Fatma EtwelJanine R. HutsonParvaz MadadiJoey GareriGideon Koren. (2014) Fetal and Perinatal Exposure to Drugs and Chemicals: Novel Biomarkers of Risk. Annual Review of Pharmacology and Toxicology 54:1, pages 295-315.
Crossref
Crossref
. (2013) Diabète et grossesse. Canadian Journal of Diabetes 37, pages S654-S657.
Crossref
Crossref
A. P. Morton. (2013) Are angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers teratogenic?. Diabetic Medicine 30:10, pages 1263-1264.
Crossref
Crossref
David Thompson, Howard Berger, Denice Feig, Robert Gagnon, Tina Kader, Erin Keely, Sharon Kozak, Edmond Ryan, Mathew Sermer & Christina Vinokuroff. (2013) Diabète et grossesse. Canadian Journal of Diabetes 37, pages S548-S566.
Crossref
Crossref
. (2013) Diabetes and Pregnancy. Canadian Journal of Diabetes 37, pages S343-S346.
Crossref
Crossref
Julia Zöllner, Ruth Curry & Mark Johnson. (2013) The contribution of heart disease to maternal mortality. Current Opinion in Obstetrics & Gynecology 25:2, pages 91-97.
Crossref
Crossref
David Thompson, Howard Berger, Denice Feig, Robert Gagnon, Tina Kader, Erin Keely, Sharon Kozak, Edmond Ryan, Mathew Sermer & Christina Vinokuroff. (2013) Diabetes and Pregnancy. Canadian Journal of Diabetes 37, pages S168-S183.
Crossref
Crossref
Janine E. Polifka. (2012) Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence. Birth Defects Research Part A: Clinical and Molecular Teratology 94:8, pages 576-598.
Crossref
Crossref
Paul Vert, Élisabeth Eléfant, M.M. Claude Dreux, Patrice Queneau, Jean-Paul Tillement, Paul Vert, Gilles Crépin, Mme Élisabeth Éléfant, Françoise Bavoux, Delphine Mitanchez & Dan Benhamou. (2012) Médicaments et adaptation néonatale : l’héritage médicamenteux. Bulletin de l'Académie Nationale de Médecine 196:3, pages 717-737.
Crossref
Crossref
Gideon Koren. (2011) ACE inhibitor use in pregnancy—setting the record straight. Nature Reviews Cardiology 9:1, pages 7-8.
Crossref
Crossref